Literature DB >> 29768539

Evaluation of prophylactic and therapeutic effects of sildenafil on acute radiation proctitis in rats.

Erkan Yavuz1, Gulcin Ercan1, Onur Olgac Karagulle1, Busra Yaprak Bayrak2, Aytac Biricik1, Candas Ercetin1, Berk Gokcek3, Hakan Yigitbas1, Ramazan Kusaslan1, Atilla Celik1, Osman Bilgin Gulcicek1.   

Abstract

PURPOSE: To investigate the prophylactic and therapeutical effects of sildenafil in a model of acute radiation proctitis (ARP).
METHODS: All experimental procedures of this study was examined by histopathological, immunohistochemical and transmission electron microscopic analysis.
RESULTS: Our histopathological evaluations indicated significant increases in lesion severity, cryptic apsis, cryptitis, cryptic distortion, reactive atypia and infiltration depth of the control (proctitis) group. While the prophylaxis group and the treatment group had significantly lower scores. High-dose group showed similar results as prophylaxis group. Histopathological findings of the prophylaxis group was more significant than the treatment group. Immunoreactivities of IL-1β, FGF-2, TNF- α and HIF-1α increased in the control group especially in the epithelial and cryptic regions. On the contrary, sildenafil application caused significant decreases of inflammatory markers in all treatment groups, specifically better results in the prophylaxis group.
CONCLUSION: The sildenafil has anti-inflammatory effects on ARP, as well as protective effects against ARP and the protective effect of sildenafil surpasses its therapeutic effect histopathologically.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29768539     DOI: 10.1590/s0102-865020180040000008

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  Investigation of HPLF-111624 in Modified Experimental Models of Ulcerative Proctitis and Anal Fissure in Rats.

Authors:  Mallappa Onkaramurthy; Mohammed Mukhram Azeemuddin; Mirza Rizwan Baig; Pavan Heggadadevanakote Kendaganna; Mohamed Rafiq; Uddagiri Venkanna Babu
Journal:  J Exp Pharmacol       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.